(2026). PARP inhibition and pharmacological ascorbate demonstrate synergy in castration‐resistant prostate cancer. Molecular Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"PARP Inhibition and Pharmacological Ascorbate Demonstrate Synergy in Castration‐resistant Prostate Cancer."
Molecular Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"PARP Inhibition and Pharmacological Ascorbate Demonstrate Synergy in Castration‐resistant Prostate Cancer."
Molecular Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.